Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
PF-07899895 by Pfizer for Ulcerative Colitis: Likelihood of Approval
PF-07899895 is under clinical development by Pfizer and currently in Phase I for Ulcerative Colitis. According to GlobalData, Phase I...